Sponsor
First Affiliated Hospital of Fujian Medical University
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name First Affiliated Hospital of Fujian Medical University appears in 31 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
31 shownProspective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate CancerNCT07562438 · lead sponsor · 2026-04-29
RECRUITINGThe Value of GRPR PET Imaging for Diagnosis and Staging in Prostate CancerNCT07363382 · lead sponsor · 2025-12-20
RECRUITINGTaining Golden Lake Comprehensive Chronic Disease Management InitiativeNCT07308314 · lead sponsor · 2025-08-01
RECRUITINGPH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary HypertensionNCT07131241 · lead sponsor · 2025-06-27
RECRUITINGResearch on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate CancerNCT07056790 · lead sponsor · 2025-05-15
RECRUITINGPSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative BiopsyNCT06923657 · lead sponsor · 2025-05-07
RECRUITINGSequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate CancerNCT07363486 · lead sponsor · 2025-04-01
RECRUITINGImproved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary OutcomesNCT06977906 · lead sponsor · 2024-01-01
RECRUITING68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRINCT07209878 · lead sponsor · 2020-01-10
RECRUITINGA Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung CancerNCT07771764 · lead sponsor · 2026-08-01
NOT_YET_RECRUITINGPredictors of BCR After RARP for Localized Prostate Cancer: A Retrospective AnalysisNCT07682584 · lead sponsor · 2026-07-15
NOT_YET_RECRUITINGDeep Brain Stimulation of the Nucleus Accumbens and Anterior Limb of the Internal Capsule in the Treatment of Refractory SchizophreniaNCT07369401 · lead sponsor · 2026-01-20
NOT_YET_RECRUITINGProspective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate CancerNCT07117760 · lead sponsor · 2025-04-22
ACTIVE_NOT_RECRUITINGAnalysis of Immediate Urinary Continence Predictors After RS-RARPNCT06850116 · lead sponsor · 2025-01-01
ACTIVE_NOT_RECRUITING68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRINCT07209865 · lead sponsor · 2024-10-01
COMPLETED68Ga-AAZTA-NI-093 PET/CT: First-in-human StudyNCT06612580 · lead sponsor · 2024-09-01
UNKNOWN68Ga-AAZTA-093 PET/CT: First-in-human StudyNCT06437496 · lead sponsor · 2024-04-01
UNKNOWNStudy of 18F-Thretide PET/CT in Patients With Prostate CancerNCT05516329 · lead sponsor · 2022-08-20
COMPLETEDAmyloid-beta PET Imaging With 18F-92 in Alzheimer's DiseaseNCT04926272 · lead sponsor · 2021-07-01
UNKNOWN68Ga-PSMA-11 PET/CT in Patients With Various Types of CancerNCT04831541 · lead sponsor · 2020-10-10
UNKNOWNClinical Study of LPI With Different Laser WavelengthsNCT02901730 · lead sponsor · 2016-09-01
UNKNOWNClinical Study of LPI on Different Sites of IrisNCT02870504 · lead sponsor · 2016-07-01
UNKNOWN99mTc-3PRGD2 SPECT/CT in Breast Cancer PatientsNCT02742168 · lead sponsor · 2016-01-01
COMPLETED99mTc-3PRGD2 SPECT/CT in Rheumatoid Arthritis PatientsNCT02723760 · lead sponsor · 2015-11-01
COMPLETEDSCAN Targeted Epidural Modulation for Parkinson's DiseaseNCT06919822 · collaborator · 2025-12-08
RECRUITINGMechanisms of Brain-Heart Injury of Post-Intracranial HemorrhageNCT06906432 · collaborator · 2024-08-01
RECRUITINGA Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney DiseaseNCT07130955 · collaborator · 2025-08-08
ENROLLING_BY_INVITATIONA Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart FailureNCT05824923 · collaborator · 2023-08-14
ACTIVE_NOT_RECRUITINGChina Antihypertensive Trial for Intracranial AneurysmNCT05941377 · collaborator · 2023-08-05
COMPLETEDEfficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma HomocysteineNCT01848873 · collaborator · 2013-01-01
UNKNOWNRisk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention IINCT05050877 · collaborator · 2000-06-01
COMPLETEDDrugs studied in this sponsor's trials
2 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing First Affiliated Hospital of Fujian Medical University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
gallium GA-68 gozetotide3
amlodipine1
Sponsor roles
lead sponsor24
collaborator7
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.